Ann: IHL Intends to Redomicile to US & List all Shares on Nasdaq, page-58

Looking back at GW Pharmaceuticals' history

The company listed it's shares on the NASDAQ as ADRs in 2014
It canceled its UK Listing in 2016

2020 - Jazz Pharmaceuticals announces its agreement to acquire GW Pharmaceuticals in a cash-and-stock deal worth approximately $7.2 billion. The acquisition is completed later that year, with GW Pharmaceuticals becoming a wholly-owned subsidiary of Jazz Pharmaceuticals.


View it here

Incannex is not the first company to ditch it's mother country, hope re can replicate some success!
GLAH